Cited by 18

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

[Retraction]MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice

Ye, Qiong, Tian, Guo-Ping, Cheng, Hai-Peng, Zhang, Xin, Ou, Xiang, Yu, Xiao-Hua, Tan, Ru-Qi, Yang, Feng-Yun, Gong, Duo, Huang, Chong, Pan, Yan-Jun, Zhang, Jie, Chen, Ling-Yan, Zhao, Zhen-Wang, Xie, Wei, Li, Liang, Zhang, Min, Xia, Xiao-Dan, Zheng, Xi-Long, Tang, Chao-Ke·2018·Journal of Atherosclerosis and Thrombosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5551/jat.40212This paper is marked retracted.

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 28

  1. 1) Liu B, Li Y, Luo J, Dai L, Zhao J, Li H, Jie Q, Wang D, Huang X, Wei Y. Low protein Z plasma level is a risk factor for acute myocardial infarction in coronary atherosclerosis disease patients. Thrombosis research. 2016; 148: 25-31 · DOI
  2. 2) Lundqvist A, Magnusson LU, Ullstrom C, Krasilnikova J, Telysheva G, Dizhbite T, Hulten LM. Oregonin reduces lipid accumulation and proinflammatory responses in primary human macrophages. Biochemical and biophysical research communications. 2015; 458: 693-699 · DOI
  3. 3) Frayn KN, Arner P, Yki-Jarvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays in biochemistry. 2006; 42: 89-103 · DOI
  4. 4) Laudati E, Gilder AS, Lam MS, Misasi R, Sorice M, Gonias SL, Mantuano E. The activities of LDL Receptor-related Protein-1 (LRP1) compartmentalize into distinct plasma membrane microdomains. Molecular and cellular neurosciences. 2016; 76: 42-51 · DOI
  5. 5) Mantuano E, Brifault C, Lam MS, Azmoon P, Gilder AS, Gonias SL. LDL receptor-related protein-1 regulates NFkappaB and microRNA-155 in macrophages to control the inflammatory response. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113: 1369-1374 · DOI
  6. 6) Lillis AP, Muratoglu SC, Au DT, Migliorini M, Lee MJ, Fried SK, Mikhailenko I, Strickland DK. Correction: LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. PloS one. 2016; 11: e0147457 · DOI
  7. 7) Deng L, Bradshaw AC, Baker AH. Role of noncoding RNA in vascular remodelling. Current opinion in lipidology. 2016; 27: 439-448 · DOI
  8. 8) Catalanotto C, Cogoni C, Zardo G. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions. International journal of molecular sciences. 2016; 17 · DOI
  9. 9) Tian GP, Chen WJ, He PP, Tang SL, Zhao GJ, Lv YC, Ouyang X P, Yin K, Wang PP, Cheng H, Chen Y, Huang SL, Fu Y, Zhang DW, Yin WD, Tang CK. MicroRNA467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie. 2012; 94: 2749-2755 · DOI
  10. 10) He PP, Ouyang XP, Tang YY, Liao L, Wang ZB, Lv YC, Tian GP, Zhao GJ, Huang L, Yao F, Xie W, Tang YL, Chen WJ, Zhang M, Li Y, Wu JF, Peng J, Liu XY, Zheng XL, Yin WD, Tang CK. MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages. Biochimie. 2014; 106: 81-90 · DOI
  11. 11) Tian GP, Tang YY, He PP, Lv YC, Ouyang XP, Zhao GJ, Tang SL, Wu JF, Wang JL, Peng J, Zhang M, Li Y, Cay abyab FS, Zheng XL, Zhang DW, Yin WD, Tang CK. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochemical and biophysical research communications. 2014; 443: 428-434 · DOI
  12. 12) Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends in endocrinology and metabolism: TEM. 2014; 25: 146-155 · DOI
  13. 13) Lichtenstein L, Kersten S. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. Biochimica et biophysica acta. 2010; 1801: 415-420 · DOI
  14. 14) Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, van der Vliet JA, de Roos A, Tamsma JT, Smit JW, Tan NS, Muller M, Rensen PC, Kersten S. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33: 1529-1537 · DOI · Paper page
  15. 15) Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, van der Meer R, He Y, Qi L, Koster A, Tamsma JT, Tan NS, Muller M, Kersten S. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell metabolism. 2010; 12: 580-592 · DOI · Paper page
  16. 16) Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochemical and biophysical research communications. 2010; 394: 792-797 · DOI
  17. 17) Lan G, Xie W, Li L, Zhang M, Liu D, Tan YL, Cheng HP, Gong D, Huang C, Zheng XL, Yin WD, Tang CK. MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages. Biochemical and biophysical research communications. 2016; 472: 410-417 · DOI · Paper page
  18. 18) Beauchamp MC, Letendre E, Renier G. Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia. Journal of lipid research. 2002; 43: 215-222 · DOI
  19. 19) Dijk W, Beigneux AP, Larsson M, Bensadoun A, Young SG, Kersten S. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. Journal of lipid research. 2016; 57: 1670-1683 · DOI · Paper page
  20. 20) Rao X, Zhong J, Maiseyeu A, Gopalakrishnan B, Villamena FA, Chen LC, Harkema JR, Sun Q, Rajagopalan S. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circulation research. 2014; 115: 770-780 · DOI
  21. 21) Oury C, Servais L, Bouznad N, Hego A, Nchimi A, Lancellotti P. MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling. International journal of molecular sciences. 2016; 17 · DOI
  22. 22) Liu Y, Zheng L, Wang Q, Hu YW. Emerging roles and mechanisms of long noncoding RNAs in atherosclerosis. International journal of cardiology. 2016; 228: 570-582 · DOI
  23. 23) Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. The Journal of pathology. 2010; 220: 71-86 · DOI
  24. 24) Giral H, Kratzer A, Landmesser U. MicroRNAs in lipid metabolism and atherosclerosis. Best practice & research Clinical endocrinology & metabolism. 2016; 30: 665-676 · DOI
  25. 25) Geldenhuys WJ, Lin L, Darvesh AS, Sadana P. Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases. Drug discovery today. 2017; 22: 352-365 · DOI
  26. 27) Geldenhuys WJ, Caporoso J, Leeper TC, Lee YK, Lin L, Darvesh AS, Sadana P. Structure-activity and in vivo evaluation of a novel lipoprotein lipase (LPL) activator. Bioorganic & medicinal chemistry letters. 2017; 27: 303-308 · DOI
  27. 28) Miller YI, Shyy JY. Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation. Trends in endocrinology and metabolism: TEM. 2017, 28: 143-152 · DOI
  28. 30) Yoshida K, Shimizugawa T, Ono M, Furukawa H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. Journal of lipid research. 2002; 43: 1770-1772 · DOI · Paper page

Cited by

Sorted by citations

See all 18

Metadata

Authors
Ye, Q., Tian, G.-P., Cheng, H.-P., Zhang, X., Ou, X., Yu, X.-H., Tan, R.-Q., Yang, F.-Y., Gong, D., Huang, C., Pan, Y.-J., Zhang, J., Chen, L.-Y., Zhao, Z.-W., Xie, W., Li, L., Zhang, M., Xia, X.-D., Zheng, X.-L., & Tang, C.-K.
Affiliations
  • Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China
  • Department of Cardiovascular Medicine, The Second Affiliated Hospital of University of South China
  • Department of Endocrinology, The First Hospital of Changsha
  • Department of Spinal Surgery, The Second Affiliated Hospital of University of South China
  • Department of Biochemistry and Molecular Biology, Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Health Sciences Center
Venue
Journal of Atherosclerosis and Thrombosis
Published
2018-03-01
Volume
25
Issue
3
Pages
244-253
ISSN
  • 1340-3478
  • 1880-3873
Cited by
18
References
2
Language
en
Status
Retracted

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review